Opko Health OPK Diagnostics — D&A
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Opko Health in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opko Health's diagnostics — d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opko Health's diagnostics — D&A?
- Opko Health (OPK) reported diagnostics — D&A of $3.93M in Q1 2026.
- How has Opko Health's diagnostics — D&A changed year-over-year?
- Opko Health's diagnostics — D&A decreased by 31.1% year-over-year, from $5.7M to $3.93M.
- What is the long-term trend for Opko Health's diagnostics — D&A?
- Over 4 years (2021 to 2025), Opko Health's diagnostics — D&A has grown at a -22.0% compound annual growth rate (CAGR), from $52.29M to $19.37M.
- What does diagnostics — D&A mean?
- This metric represents the non-cash expense allocated to the Diagnostics segment for the wear and tear of tangible assets and the systematic write-down of intangible assets over their useful lives. It reflects the capital intensity required to maintain the diagnostic testing infrastructure and technology platforms.